Serial Number
79288877
Owner
Telix Pharmaceuticals LimitedAttorney
Andrew S. EhardFiling Date
Mar 2, 2020
RADMAB Trademark
Serial Number: 79288877 • Registration: 6253802
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Correspondence Address
Andrew S. Ehard Merchant & Gould P.C.
P.O. Box 2910
Minneapolis, MN 55402-0910
UNITED STATES
Trademark Details
Filing Date
March 2, 2020
Registration Date
January 26, 2021
Published for Opposition
November 10, 2020
Goods & Services
Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer; diagnostic kits comprising medical diagnostic radiopharmaceutical reagents and assays for testing of bodily fluids and tissue for use in detecting cancer and also consisting of vials, needleless drug delivery devices, swabable vial adaptors and medical syringes; all of the foregoing containing monoclonal antibodies
Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices for diagnostic radiopharmaceuticals; medical device for treating cancer; diagnostic imaging apparatus for medical use; applicators for pharmaceutical preparations, namely, drug delivery devices sold empty being syringes, infusion sets and catheters
Scientific research; scientific research in the field of pharmacy; research on the subject of pharmaceuticals; medical research; research and development of products; providing scientific advisory services relating to immunological products; provision of scientific information in the fields of biochemistry, biotechnology and clinical trials; scientific consultancy, namely, consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science all of the aforementioned in relation to radiopharmaceuticals and cancer
